Nerve Growth Factor Enhances Tau Isoform Expression and Transcription in IMR32 Cells

DOI: 10.4236/nm.2014.52015   PDF   HTML   XML   3,694 Downloads   5,278 Views   Citations


The present study characterized the nerve growth factor (NGF)-mediated regulation of tau protein expression and transcription in IMR32 human neuroblastoma cells. Treatment of IMR32 cells with 50 ng/mL NGF resulted in increased levels of specific tau protein isoforms. A 550 bp fragment of the tau promoter was cloned and treatment of transfected IMR32 and PC12 cells with NGF also resulted in increased promoter activation, suggesting that the NGF-mediated increase in tau isoforms is regulated, at least in part, at the level of transcription. Pretreatment with the MAP kinase inhibitor U0126 or the PKC inhibitor bisindolylmaleimide 1 (BIS-1) attenuated the NGF-mediated increase in tau transcription, indicating that the NGF-mediated activation of the MAP kinase and PKC signaling pathways modulate tau transcription. Pre-treatment of cells with the Akt inhibitor, LY294002 or with NOS inhibitors Nω-nitro-L-arginine methylester (L-NAME) or s-methylisothiourea (S-MIU) had no effect on the NGF-mediated increase in tau promoter activation, suggesting that NO and the NGF-Akt signaling pathway do not modulate tau transcription. Taken together, these data demonstrate that NGF increases the levels of multiple human tau isoforms in IMR32 cells which may result, at least in part, from NGF-mediated PKC and MAP kinase-induced tau transcription.

Share and Cite:

Cragg, C. and Kalisch, B. (2014) Nerve Growth Factor Enhances Tau Isoform Expression and Transcription in IMR32 Cells. Neuroscience and Medicine, 5, 119-130. doi: 10.4236/nm.2014.52015.

Conflicts of Interest

The authors declare no conflicts of interest.


[1] Binder, L.I., Frankfurter, A. and Rebhun, L.I. (1985) The Distribution of Tau in the Mammalian Central Nervous System. Journal of Cell Biology, 101, 1371-1378.
[2] Cleveland, D.W., Hwo, S.Y. and Kirschner, M.W. (1977) Purification of Tau, a Microtubule-Associated Protein That Induces Assembly of Microtubules from Purified Tubulin. Journal of Molecular Biology, 116, 207-225.
[3] Drubin, D.G., Feinstein, S.C., Shooter, E.M. and Kirschner, M.W. (1985) Nerve Growth Factor-Induced Neurite Outgrowth in PC12 Cells Involves the Coordinate Induction of Microtubule Assembly and Assembly-Promoting Factors. Journal of Cell Biology, 101, 1799-1807.
[4] Weingarten, M.D., Lockwood, A.H., Hwo, S.Y. and Kirschner, M.W. (1975) A Protein Factor Essential for Microtubule Assembly. Proceedings of the National Academy of Sciences of the United States of America, 72, 1858-1862.
[5] Mandelkow, E.M., Stamer, K., Vogel, R., Thies, E. and Mandelkow, E. (2003) Clogging of Axons by Tau, Inhibition of Axonal Traffic and Starvation of Synapses. Neurobiology of Aging, 24, 1079-1085.
[6] Andreadis, A. (2005) Tau Gene Alternative Splicing: Expression Patterns, Regulation and Modulation of Function in Normal Brain and Neurodegenerative Diseases. Biochimica et Biophysica Acta, 1739, 91-103.
[7] Billingsley, M.L. and Kincaid, R.L. (1997) Regulated Phosphorylation and Dephosphorylation of Tau Protein: Effects on Microtubule Interaction, Intracellular Trafficking and Neurodegeneration. Biochemical Journal, 323, 577-591.
[8] Kosik, K.S., Joachim, C.L. and Selkoe, D.J. (1986) Microtubule-Associated Protein Tau (Tau) Is a Major Antigenic Component of Paired Helical Filaments in Alzheimer Disease. Proceedings of the National Academy of Sciences of the United States of America, 83, 4044-4048.
[9] Lovestone, S. and Reynolds, C.H. (1997) The Phosphorylation of Tau: A Critical Stage in Neurodevelopment and Neurodegenerative Processes. Neuroscience, 78, 309-324.
[10] Mandelkow, E.M., Biernat, J., Drewes, G., Gustke, N., Trinczek, B. and Mandelkow, E. (1995) Tau Domains, Phosphorylation, and Interactions with Microtubules. Neurobiology of Aging, 16, 355-362; discussion: 362-363.
[11] Ng, N.F. and Shooter, E.M. (1993) Activation of p21ras by Nerve Growth Factor in Embryonic Sensory Neurons and PC12 Cells. Journal of Biological Chemistry, 268, 25329-25333.
[12] Wood, J.G., Mirra, S.S., Pollock, N.J. and Binder, L.I. (1986) Neurofibrillary Tangles of Alzheimer Disease Share Antigenic Determinants with the Axonal Microtubule-Associated Protein Tau (Tau). Proceedings of the National Academy of Science United States of America, 83, 4040-4043.
[13] Smith, C.J., Anderton, B.H., Davis, D.R. and Gallo, J.M. (1995) Tau Isoform Expression and Phosphorylation State during Differentiation of Cultured Neuronal Cells. Federation of European Biochemical Societies Letters, 375, 243-248.
[14] Andreadis, A., Wagner, B.K., Broderick, J.A. and Kosik, K.S. (1996) A Tau Promoter Region without Neuronal Specificity. Journal of Neurochemistry, 66, 2257-2263.
[15] Nunez, J. and Fischer, I. (1997) Microtubule-Associated Proteins (MAPs) in the Peripheral Nervous System during Development and Regeneration. Journal of Molecular Neuroscience, 8, 207-222.
[16] Thurston, V.C., Pena, P., Pestell, R. and Binder, L.I. (1997) Nucleolar Localization of the Microtubule-Associated Protein Tau in Neuroblastomas Using Sense and Anti-Sense Transfection Strategies. Cell Motility and the Cytoskeleton, 38, 100-110.<100::AID-CM9>3.0.CO;2-C
[17] Sadot, E., Heicklen-Klein, A., Barg, J., Lazarovici, P. and Ginzburg, I. (1996) Identification of a Tau Promoter Region Mediating Tissue-Specific-Regulated Expression in PC12 Cells. Journal of Molecular Biology, 256, 805-812.
[18] Sergeant, N., Delacourte, A. and Buée, L. (2005) Tau Protein as a Differential Biomarker of Tauopathies. Biochimica et Biophysica Acta (BBA), Molecular Basis of Disease, 1739, 179-197.
[19] Lee, G. and Leugers, C.G. (2012) Tau and Tauopathies. Progress in Molecular Biology and Translational Science, 107, 263-293.
[20] Andreadis, A., Brown, W.M. and Kosik, K.S. (1992) Structure and Novel Exons of the Human Tau Gene. Biochemistry, 31, 10626-10633.
[21] Drubin, D.G., Miller, K.G. and Botstein, D. (1988) Yeast Actin-Binding Proteins: Evidence for a Role in Morphogenesis. Journal of Cell Biology, 107, 2551-2561.
[22] Sadot, E., Barg, J., Rasouly, D., Lazarovici, P. and Ginzburg, I. (1995) Short- and Long-Term Mechanisms of Tau Regulation in PC12 Cells. Journal of Cellular Science, 108, 2857-2864.
[23] Heicklen-Klein, A., Aronov, S. and Ginzburg, I. (2000) Tau Promoter Activity in Neuronally Differentiated P19 Cells. Brain Research, 874, 1-9.
[24] Heicklen-Klein, A. and Ginzburg, I. (2000) Tau Promoter Confers Neuronal Specificity and Binds Sp1 and AP-2. Journal of Neurochemistry, 75, 1408-1418.
[25] Kalisch, B.E., Bock, N.A., Davis, W.L. and Rylett, R.J. (2002) Inhibitors of Nitric Oxide Synthase Attenuate Nerve Growth Factor-Mediated Increases in Choline Acetyltransferase Expression in PC12 Cells. Journal of Neurochemistry, 81, 624-635.
[26] Peunova, N. and Enikolopov, G. (1995) Nitric Oxide Triggers a Switch to Growth Arrest during Differentiation of Neuronal Cells. Nature, 375, 68-73.
[27] Sheehy, A.M., Phung, Y.T., Riemer, R.K. and Black, S.M. (1997) Growth Factor Induction of Nitric Oxide Synthase in Rat Pheochromocytoma Cells. Molecular Brain Research, 52, 71-77.
[28] Binnington, J.C. and Kalisch, B.E. (2007) Nitric Oxide Synthase Inhibitors Modulate Nerve Growth Factor-Mediated Regulation of Amyloid Precursor Protein Expression in PC12 Cells. Journal of Neurochemistry, 101, 422-433.
[29] Phung, Y.T., Bekker, J.M., Hallmark, O.G. and Black, S.M. (1999) Both Neuronal NO Synthase and Nitric Oxide Are Required for PC12 Cell Differentiation: A cGMP Independent Pathway. Molecular Brain Research, 64, 165-178.
[30] Kalisch, B.E., Demeris, C.S., Ishak, M. and Rylett, R.J. (2003) Modulation of Nerve Growth Factor-Induced Activation of MAP Kinase in PC12 Cells by Inhibitors of Nitric Oxide Synthase. Journal of Neurochemistry, 87, 1321-1332.
[31] Cheryl, L., Cragg, C.L., MacKinnon, J.C. and Kalisch, B.E. (2012) Nitric Oxide Synthase Inhibitors Modulate Nerve-Growth-Factor Mediated Activation of Akt. ISRN Cell Biology, 2012, Article ID: 847974.
[32] Mackinnon, J.C., Huether, P. and Kalisch, B.E. (2012) Effects of Nerve Growth Factor and Nitric Oxide Synthase Inhibitors on Amyloid Precursor Protein mRNA Levels and Protein Stability. Open Biochemistry Journal, 6, 31-39.
[33] Grana, T.R., LaMarre, J. and Kalisch, B.E. (2013) Nerve Growth Factor-Mediated Regulation of Low Density Lipoprotein Receptor-Related Protein Promoter Activation. Cellular and Molecular Neurobiology, 33, 269-282.
[34] Sandhu, F.A., Kim, Y., Lapan, K.A., Salim, M., Aliuddin, V. and Zain, S.B. (1996) Expression of the C Terminus of the Amyloid Precursor Protein Alters Growth Factor Responsiveness in Stably Transfected PC12 Cells. Proceedings of the National Academy of Sciences United States of America, 93, 2180-2185.
[35] Ko, L.W., Sheu, K.F., Young, O., Thaler, H. and Blass, J.P. (1990) Expression in Cultured Human Neuroblastoma Cells of Epitopes Associated with Affected Neurons in Alzheimer’s Disease. American Journal of Pathology, 136, 867-879.
[36] Bradford, M.M. (1976) A Rapid and Sensitive Method for the Quantitation of Microgram Quantities of Protein Utilizing the Principle of Protein-Dye Binding. Analalytical Biochemistry, 72, 248-254.
[37] Baskey, J.C., Kalisch, B.E., Davis, W.L., Meakin, S.O. and Rylett, R.J. (2002) PC12nnr5 Cells Expressing TrkA Receptors Undergo Morphological but Not Cholinergic Phenotypic Differentiation in Response to Nerve Growth Factor. Journal of Neurochemistry, 80, 501-511.
[38] Alonso, A.D., Zaidi, T., Novak, M., Barra, H.S., Grundke-Iqbal I. and Iqbal, K. (2001) Interaction of Tau Isoforms with Alzheimer’s Disease Abnormally Hyperphosphorylated Tau and in Vitro Phosphorylation into the Disease-Like Prtein. Journal of Biological Chemistry, 276, 37967-37973.
[39] Sáez, E.T., Pehar, M., Vargas, M.R., Barbeito, L. and Maccioni, R.B. (2006) Production of Nerve Growth Factor by β-Amyloid-Stimulated Astrocytes Induces p75NTR-Dependent Tau Hyperphosphorylation in Cultured Hippocampal Neurons. Journal of Neuroscience Research, 84, 1098-1106.
[40] Zhang, Z.H., Xi, G.M., Li, W.C., Ling, H.Y., Qu, P. and Fang, X.B. (2012) Cyclic-AMP Response Element Binding Protein and Tau Are Involved in the Neuroprotective Mechanisms of Nerve Growth Factor during Focal Cerebral Ischemia/Reperfusion in Rats. Journal of Clinical Neuroscience, 17, 353-356.
[41] Bleasdale, J.E., Thakur, N.R., Gremban, R.S., Bundy, G.L., Fitzpatrick, F.A., Smith, R.J. and Bunting, S. (1990) Selective Inhibition of Receptor-Coupled Phospholipase C-Dependent Processes in Human Platelets and Polymorphonuclear Neutrophils. Journal of Pharmacology and Experimental Therapeutics, 255, 756-768.
[42] Jones, N.P., Peak, J., Brader, S., Eccles, S.A. and Katan, M. (2005) PLCgamma1 Is Essential for Early Events in Integrin Signalling Required for Cell Motility. Journal of Cell Science, 118, 2695-2706.
[43] Sato, K., Tokmakov, A.A., Iwasaki, T. and Fukami, Y. (2000) Tyrosine Kinase-Dependent Activation of Phospholipase Cgamma Is Required for Calcium Transient in Xenopus Egg Fertilization. Developmental Biology, 224, 453-469.
[44] Smith, R.J., Sam, L.M., Justen, J.M., Bundy, G.L., Bala, G.A. and Bleasdale, J.E. (1990) Receptor-Coupled Signal Transduction in Human Polymorphonuclear Neutrophils: Effects of a Novel Inhibitor of Phospholipase C-Dependent processes on Cell Responsiveness. Journal of Pharmacology and Experimental Therapeutics, 253, 688-697.
[45] Zapf-Colby, A., Eichhorn, J., Webster, N.J. and Olefsky, J.M. (1999) Inhibition of PLC-Gamma1 Activity Converts Nerve Growth Factor from an Anti-Mitogenic to a Mitogenic Signal in CHO Cells. Oncogene, 18, 4908-4919.
[46] Martiny-Baron, G., Kazanietz, M.G., Mischak, H., Blumberg, P.M., Kochs, G., Hug, H., Marmé, D. and Schächtele, C. (1993) Selective Inhibition of Protein Kinase C Isozymes by the Indolocarbazole Gö 6976. Journal of Biological Chemistry, 268, 9194-9197
[47] Toullec, D., Pianetti, P., Coste, H., Bellevergue, P., Grand-Perret, T., Ajakane, M., Baudet, V., Boissin, P., Boursier, E., Loriolle, F., Duhamelll, L., Charon, D. and Kirilovsky, J. (1991) The Bisindolylmaleimide GF 109203X Is a Potent and Selective Inhibitor of Protein Kinase C. Journal of Biological Chemistry, 266, 15771-15781.
[48] Bapat, S., Verkleij, A. and Post, J.A. (2001) Peroxynitrite Activates Mitogen-Activated Protein Kinase (MAPK) via a MEK-Independent Pathway: A Role for Protein Kinase C. Federation of European Biological Societies Letters, 499, 21-26.
[49] Liang, L.M. and Knox, F.G. (1999) Nitric Oxide Activates PKCalpha and Inhibits Na+-K+-ATPase in Opossum Kidney Cells. American Journal of Physiology, 277, F859-F865.
[50] Lichvárová, L., Jasková, K. and Lacinová, K. (2012) NGF-Induced Neurite Outgrowth in PC12 Cells Is Independent of Calcium Entry through L-Type Calcium Channels. General Physiology and Biophysics, 31, 473-478.
[51] Dupont, J.L., Janoshazi, A., Bellahcene, M., Mykita, S. and De Barry, J. (2000) Reversible Protein Kinase C Activation in PC12 Cells: Effect of NGF Treatment. European Journal of Neuroscience, 12, 215-226.
[52] Park, S.Y., Lee, J.Y., Choi, J.Y., Park, M.J. and Kim, D.S. (2006) Nerve Growth Factor Activates Brain-Derived Neurotrophic Factor Promoter IV via Extracellular Signal-Regulated Protein Kinase 1/2 in PC12 Cells. Molecules and Cells, 21, 237-243.
[53] Corbit, K.C., Foster, D.A. and Rosner, M.R. (1999) Protein Kinase Cδ Mediates Neurogenic but Not Mitogenic Activation of Mitogen-Activated Protein Kinase in Neuronal Cells. Molecular and Cell Biology, 19, 4209-4218.
[54] Li, P., Yamakuni, T., Matsunaga, K., Kondo, S. and Ohizumi, Y. (2003) Nardosinone Enhances Nerve Growth Factor-Induced Neurite Outgrowth in a Mitogen-Activated Protein Kinase- and Protein Kinase C-dependent Manner in PC12D Cells. Journal of Pharmacological Science, 93, 122-125.
[55] Billon, N., Carlisi, D., Datto, M.B., van Grunsven, L.A., Watt, A., Wang, X.F. and Rudkin, B.B. (1999) Cooperation of Sp1 and p300 in the Induction of the CDK Inhibitor p21WAF1/CIP1 during NGF-Mediated Neuronal Differentiation. Oncogene, 18, 2872-2882.
[56] Park, K.M., Yule, D.I. and Bowers, W.J. (2009) Tumor Necrosis Factor-Alpha-Mediated Regulation of the Inositol 1, 4,5-Trisphosphate Receptor Promoter. Journal of Biological Chemistry, 284, 27557-27566.
[57] Benasciutti, E., Pagès, G., Kenzior, O., Folk, W., Blasi, F. and Crippa, M.P. (2004) MAPK and JNK Transduction Pathways Can Phosphorylate Sp1 to Activate the uPA Minimal Promoter Element and Endogenous Gene Transcription. Blood, 104, 256-262.
[58] Lee, S.J., Park, S.S., Cho, Y.H., Park, K., Kim, E.J., Jung, K.H., Kim, S.K., Kim, W.J. and Moon, S.K. (2008) Activation of Matrix Metalloproteinase-9 by TNF-Alpha in Human Urinary Bladder Cancer HT1376 Cells: The Role of MAP Kinase Signaling Pathways. Oncology Reports, 19, 1007-1013.
[59] Bai, S., Ghoshal, K., Datta, J., Majumder, S., Yoon, S.O. and Jacob, S.T. (2005) DNA Methyltransferase 3b Regulates Nerve Growth Factor-Induced Differentiation of PC12 Cells by Recruiting Histone Deacetylase 2. Molecular and Cellular Biology, 25, 751-766.
[60] Kato, A., Endo, T., Abiko, S., Ariga, H. and Matsumoto, K. (2008) Induction of Truncated Form of Tenascin-X (XB-S) through Dissociation of HDAC1 from SP-1/HDAC1 Complex in Response to Hypoxic Conditions. Experimental Cell Research, 314, 2661-2673.

comments powered by Disqus

Copyright © 2020 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.